1. FRI0495 What Might be the Factors for Staying in Remission in JIA? Data from the German Biker Registry. (9th June 2015) Authors: Peitz, J.; Becker, I.; Horneff, G. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Infliximab is an appropriate second‐line therapy in infants with steroid refractory pyoderma gangrenosum. (27th January 2022) Authors: Lesmeister, L.M.; Peitz, J.; von Kleist‐Retzow, J.C.; Lee‐Kirsch, M.A.; Torrelo, A.; Tantcheva‐Poor, I.; Broekaert, I.J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 5(2022) Page Start: e376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0573 15-year trends and correlates of school sports attendance among children and adolescents with jia enrolled in the german national paediatric rheumatologic database. (12th June 2018) Authors: Milatz, F.; Klotsche, J.; Niewerth, M.; Geisemeyer, N.; Hansmann, S.; Hartmann, M.; Kallinich, T.; Peitz, J.; Trauzeddel, R.; Minden, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗